Injective Protocol
New York, NY 00000
United States

Open map

KANDO id: 1051908

Corporate information

Registration country
Affiliated coins

Company type

DeFi protocols for cross-chain derivatives trading


Injective Protocol is one of the first universal “DeFi” (Decentralised Finance) protocols for cross-chain derivatives trading, so the launch of the Testnet is an important milestone. Injective’s main competitors (centralized and decentralized exchanges) include CME Group, BitMEX, LedgerX and OKEx, among others.

Funding rounds

Seed USD 10,000,000

( )

Profile Country Notes
Pantera Capital Management LP Investment firm focused exclusively on ventures, tokens, and projects related to blockchain tech, digital currency, and crypto assets. Initial investment. Led the round.
#Hashed Global, early stage venture fund focused on backing founders who are pioneering the future of blockchain and cryptocurrency. Initial investment.
BlockTower Capital Advisors Cryptocurrency investment firm, bringing professional trading and portfolio management to an emerging digital asset class. Initial investment.
Cadenza Capital Management Initial investment.
QCP Capital Pte Ltd Full-suite crypto-asset trading firm that has a vision to adopt blockchain and cryptocurrency to various industries. Initial investment.
Mark Cuban Individual investor. Initial investment.

Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers